TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-12-11
公報種別公開国際商標公報
国際登録番号1814833
国際登録日2024-07-25
区分第5類(薬剤),第10類(医用機器),第44類(医療・農林業)
商品役務Diagnostic preparations for medical or veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; kits containing preparations for medical and veterinary diagnostic purposes, in particular for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids全 65 件を表示, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; chemical reagents for medical purposes; cartridges containing medical diagnostic reagents for use in Polymerase Chain Reaction (PCR) or digital Polymerase Chain Reaction (PCR) instruments; medical diagnostic assays for testing of body samples, including bodily fluids and tissue in the detection, monitoring, and prediction of disease or other conditions, disease states, hormone level, drug level, drug response, organ function effectiveness, and clinical response; diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics.,Apparatus for medical and veterinary diagnostic analysis and determination of medical and veterinary conditions, namely DNA and RNA testing apparatus; Medical and veterinary equipment for diagnostic purposes; clinical medical laboratory apparatus and analytical instruments, namely digital Polymerase Chain Reaction (d PCR) instruments for use in in-vitro and in-vivo diagnostics; medical devices for detection of infectious disease, namely, digital polymerase chain reaction (dPCR) platforms; medical devices for use in pre-natal screenings, namely, digital polymerase chain reaction (dPCR) platform; medical devices, namely, digital polymerase chain reaction (dPCR) instruments for use in detecting, diagnosing and treating cancer and infectious disease, namely, digital polymerase chain reaction (dPCR) platform; medical devices, namely, digital polymerase chain reaction (dPCR) instruments for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital polymerase chain reaction (dPCR) platform; microfluidic plates for use as medical apparatus.,Testing services, namely, quantifying DNA and RNA for medical, diagnostic and treatment purposes; rental of digital Polymerase Chain Reaction (PCR) apparatus; RNA or DNA analysis for cancer diagnosis and prognosis; Medical services, in particular medical analysis in connection with the treatment of individuals; providing information in the fields of medicine, veterinary medicine and pharmaceuticals; health centers, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children’s hospitals and women’s hospital; medical clinics; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseases; medical laboratory services for the analysis of samples taken from patients.
基礎出願番号018987549
基礎出願日2024-02-19
基礎出願国EM
出願人QIAGEN GmbH
OCRテキストOIAcuityDx
OCRテキスト2QIAcuityDx
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

QIAGEN GmbH
QIAcuityDx
7日前
Novo Nordisk A/S
Zilconyc
28日前
Boehringer Ingelheim International GmbH
BEKTUYU
2か月前
Drink LMNT, Inc.
Ε
21日前
CELSIUS HOLDINGS, INC.
Metaplus
14日前
Hunan Xizi Health Group Co., Ltd.
fiboo
14日前
Straumann Holding AG
Xenooss
21日前
Suninflam Ltd.
suninflam
21日前
Novo Nordisk A/S
Zilkonir
21日前
FibroGen, Inc.
PET46
21日前
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
正大天晴| CHIATAITIANQING
21日前
Ollin Biosciences Inc.
OLLIN
14日前
Cirkul, Inc.
CIRKOLA
21日前
Perelel Inc.
PERELEL
21日前
Precigen, Inc.
PAPZIMEOS
21日前
Novo Nordisk A/S
Ziltanir
21日前
Anthos Therapeutics, Inc.
DUVALXI
21日前
Anthos Therapeutics, Inc.
XXIABELA
21日前
Nordic Bioscience A/S
nordicEndotrophin
14日前
Biocomposites International Limited
SYNICEM
14日前
Anthos Therapeutics, Inc.
OBRYXI
21日前
Viela Bio, Inc.
XUBLEANT
14日前
Harrow IP, LLC
IHEEZO
14日前
Harrow IP, LLC
HARROW
14日前
Harrow IP, LLC
O
14日前
Harrow IP, LLC
IHEEZO (chloroprocaineHClophthalmicgel)3%
14日前
Merck Sharp & Dohme B.V.
14日前
Merck Sharp & Dohme B.V.
14日前
Viela Bio, Inc.
DAXFYTRA
14日前
XENON PHARMACEUTICALS INC.
XENON
14日前
Remix Therapeutics Inc.
REMIXTHERAPEUTICS
14日前
Neurotech Pharmaceuticals, Inc.
O neurotech
14日前
Neurotech Pharmaceuticals, Inc.
O neurotech PHARMACEUTICALS
14日前
Neurotech Pharmaceuticals, Inc.
14日前
BLUE ORIGIN MANAGEMENT CONSULTANT PTE. LTD.
OH! SOME
14日前
HuonsLab Co., Ltd.
HYDIFFUZE
14日前
続きを見る